Dynavax Financial Statements From 2010 to 2026

DVAX Stock  USD 15.50  0.01  0.06%   
Dynavax Technologies' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Dynavax Technologies' valuation are provided below:
Gross Profit
203.6 M
Profit Margin
(0.13)
Market Capitalization
1.8 B
Enterprise Value Revenue
4.2303
Revenue
330.5 M
We have found one hundred twenty available fundamental signals for Dynavax Technologies, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of Dynavax Technologies prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road.

Dynavax Technologies Total Revenue

334.77 Million

Check Dynavax Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dynavax Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.8 M, Interest Expense of 4.2 M or Other Operating Expenses of 339.8 M, as well as many indicators such as Price To Sales Ratio of 5.12, Dividend Yield of 0.0 or PTB Ratio of 4.39. Dynavax financial statements analysis is a perfect complement when working with Dynavax Technologies Valuation or Volatility modules.
  
Build AI portfolio with Dynavax Stock
Check out the analysis of Dynavax Technologies Correlation against competitors.
For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.

Dynavax Technologies Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.2 B1.1 B492.2 M
Slightly volatile
Other AssetsM3.2 M3.9 M
Slightly volatile
Common Stock Shares Outstanding161 M153.3 M76.2 M
Slightly volatile
Liabilities And Stockholders Equity1.2 B1.1 B492.2 M
Slightly volatile
Other Stockholder Equity1.8 B1.7 B1.1 B
Slightly volatile
Total Liabilities470.3 M447.9 M226.5 M
Slightly volatile
Other Current Liabilities79 M75.2 M48.5 M
Slightly volatile
Total Current Liabilities59.4 M90.4 M77.6 M
Slightly volatile
Accounts Payable10.9 M10.4 M4.6 M
Slightly volatile
Cash63.6 M110.3 M81.9 M
Slightly volatile
Short Term Investments746.2 M710.6 M256.4 M
Slightly volatile
Other Current Assets21.8 M20.9 M28.7 M
Slightly volatile
Common Stock86.2 K143.8 K103.6 K
Very volatile
Property Plant Equipment45.4 M43.2 M24.8 M
Slightly volatile
Property Plant And Equipment Net73.2 M69.7 M35.6 M
Slightly volatile
Non Current Assets Total165.8 M157.9 M61.4 M
Slightly volatile
Non Currrent Assets Other3.5 M3.7 M8.7 M
Slightly volatile
Cash And Short Term Investments862 M820.9 M342.4 M
Slightly volatile
Common Stock Total Equity85 K147.2 K103.8 K
Very volatile
Non Current Liabilities Total375.3 M357.4 M155.4 M
Slightly volatile
Property Plant And Equipment Gross114.4 M109 M44.2 M
Slightly volatile
Total Current AssetsB976.3 M431 M
Slightly volatile
Net Receivables56.6 M53.9 M31.4 M
Slightly volatile
Other Liabilities328.3 K345.6 K3.1 M
Slightly volatile
Good Will1.8 M1.8 M2.1 M
Slightly volatile
Intangible Assets3.2 M2.9 M3.1 M
Very volatile
Short and Long Term Debt Total160.8 M292.6 M139.7 M
Slightly volatile
Short Term Debt4.5 M3.8 M4.8 M
Slightly volatile
Net Tangible Assets699.2 M665.9 M268.3 M
Slightly volatile
Capital Surpluse1.1 B1.7 B1.1 B
Slightly volatile
Non Current Liabilities Other266.6 K280.6 K7.7 M
Pretty Stable
Long Term Debt Total167 M254.8 M124.5 M
Slightly volatile
Short and Long Term Debt7.6 M8.6 M9.4 M
Slightly volatile
Net Invested Capital508.7 M943.8 M385.2 M
Slightly volatile
Net Working Capital930.1 M885.9 M369 M
Slightly volatile
Capital Stock119.9 K143.8 K90 K
Slightly volatile
Capital Lease Obligations28.2 M27.5 M35.7 M
Slightly volatile

Dynavax Technologies Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses339.8 M323.6 M180.8 M
Slightly volatile
Research Development52.5 M70.8 M56.8 M
Very volatile
Total Operating Expenses280 M266.7 M139.2 M
Slightly volatile
Total Revenue334.8 M318.8 M146.3 M
Slightly volatile
Cost Of Revenue52.2 M56.9 M67 M
Pretty Stable
Minority Interest18.6 M17.8 M14.9 M
Slightly volatile
Selling General Administrative205.7 M195.9 M80.1 M
Slightly volatile
Preferred Stock And Other Adjustments6.8 M7.6 M8.3 M
Slightly volatile
Non Recurring16.1 M15.4 MM
Slightly volatile
Interest Income44 M41.9 M10 M
Slightly volatile
Selling And Marketing Expenses24.9 M28.5 M17.4 M
Slightly volatile
Reconciled Depreciation7.8 M7.2 M7.3 M
Slightly volatile

Dynavax Technologies Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditures5.5 M7.3 MM
Slightly volatile
End Period Cash Flow63.7 M110.6 M82 M
Slightly volatile
Begin Period Cash Flow181.8 M173.1 M88.3 M
Slightly volatile
Depreciation5.1 M9.3 M6.1 M
Slightly volatile
Stock Based Compensation63.5 M60.5 M24.1 M
Slightly volatile
Change To Netincome79.1 M75.3 M34.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio5.125.39205
Very volatile
Days Sales Outstanding10155.58141
Very volatile
Stock Based Compensation To Revenue0.160.173.4679
Very volatile
Capex To Depreciation1.10.711.4186
Pretty Stable
EV To Sales5.615.91200
Very volatile
Inventory Turnover0.770.812.4591
Slightly volatile
Days Of Inventory On Hand711595352
Slightly volatile
Payables Turnover4.674.9110.9098
Slightly volatile
Sales General And Administrative To Revenue0.530.556.7838
Very volatile
Research And Ddevelopement To Revenue0.190.215.7267
Pretty Stable
Capex To Revenue0.01960.02060.4991
Pretty Stable
Cash Per Share6.06.3114.9799
Slightly volatile
Days Payables Outstanding73.0776.92739
Slightly volatile
Intangibles To Total Assets0.00220.00230.0158
Slightly volatile
Current Ratio7.3512.427.1575
Pretty Stable
Receivables Turnover9.16.85.458
Very volatile
Graham Number9.345.356.0844
Slightly volatile
Debt To Equity0.360.382.4281
Very volatile
Capex Per Share0.05340.05620.2751
Slightly volatile
Revenue Per Share3.982.452.3765
Pretty Stable
Interest Debt Per Share1.31.811.4684
Slightly volatile
Debt To Assets0.250.230.3117
Pretty Stable
Operating Cycle336521417
Slightly volatile
Days Of Payables Outstanding73.0776.92739
Slightly volatile
Long Term Debt To Capitalization0.50.310.4255
Pretty Stable
Total Debt To Capitalization0.340.270.4251
Pretty Stable
Debt Equity Ratio0.360.382.4281
Very volatile
Quick Ratio7.1611.396.8837
Pretty Stable
Net Income Per E B T0.850.80.9907
Very volatile
Cash Ratio1.641.41.3022
Pretty Stable
Days Of Inventory Outstanding711595352
Slightly volatile
Days Of Sales Outstanding10155.58141
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.161.041.043
Very volatile
Fixed Asset Turnover2.344.122.6322
Slightly volatile
Debt Ratio0.250.230.3117
Pretty Stable
Price Sales Ratio5.125.39205
Very volatile
Asset Turnover0.160.250.1776
Slightly volatile

Dynavax Technologies Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap332.3 M373.8 M408 M
Slightly volatile
Enterprise Value317 M356.6 M389.2 M
Slightly volatile

Dynavax Fundamental Market Drivers

Forward Price Earnings29.2398
Cash And Short Term Investments713.8 M

Dynavax Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Dynavax Technologies Financial Statements

Dynavax Technologies investors use historical fundamental indicators, such as Dynavax Technologies' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dynavax Technologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue60.3 M31 M
Total Revenue318.8 M334.8 M
Cost Of Revenue56.9 M52.2 M
Stock Based Compensation To Revenue 0.17  0.16 
Sales General And Administrative To Revenue 0.55  0.53 
Research And Ddevelopement To Revenue 0.20  0.19 
Capex To Revenue 0.02  0.02 
Revenue Per Share 2.45  3.98 
Ebit Per Revenue(0.02)(0.02)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Dynavax Stock Analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.